Senate Finance Committee Delays FDA Approval of Vagus Nerve Stimulation Therapy for Depression
On June 15th, 2004, FDA’s Medical Devices Panel recommended that the U.S. Food and Drug Administration approve vagus nerve stimulation as a therapy for chronic or recurrent treatment-resistant depression. Senate Finance Committee Delays FDA Approval of Vagus Nerve Stimulation Therapy for Depression Updates
Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically to your feed reader.
Comments
No comments yet.
Leave a comment